Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.
Journal
Crohn's & colitis 360
ISSN: 2631-827X
Titre abrégé: Crohns Colitis 360
Pays: England
ID NLM: 101752188
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
13
2
2023
pubmed:
17
12
2020
medline:
17
12
2020
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1093/crocol/otaa049.].
Identifiants
pubmed: 36780244
doi: 10.1093/crocol/otaa092
pii: otaa092
pmc: PMC9802177
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
otaa092Commentaires et corrections
Type : ErratumFor
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.